Fate Therapeutics(FATE) - 2024 Q1 - Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Results Conference Call May 9, 2024 5:00 PM ET Company Participants Scott Wolchko - President and CEO Ed Dulac - CFO Bob Valamehr - Chief Research and Development Officer Conference Call Participants Michael Yee - Jefferies Ashiq Mubarack - Citi Jeff LaRosa - Leerink Partners Rohit Bhasin - Morgan Stanley Li Watsek - Cantor Fitzgerald Greg Williams - TD Cowen Carolina Ibanez-Ventoso - Stifel Alex Bouilloux - Barclays Yanan Zhu - Wells Fargo Securities Bill Maugh ...